Detection of a new polymorphism in the PAI-1 gene located in the pro-peptide coding region
- 1 January 1999
- journal article
- Published by Elsevier in Fibrinolysis and Proteolysis
- Vol. 13 (1) , 26-30
- https://doi.org/10.1016/s0268-9499(99)90012-7
Abstract
No abstract availableKeywords
Funding Information
- Karolinska Institutet
- Medicinska Forskningsrådet (05 193)
- Hjärt-Lungfonden
This publication has 16 references indexed in Scilit:
- The PAI-1 Gene Locus 4G/5G Polymorphism Is Associated With a Family History of Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Tissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA/inhibitor complexesScandinavian Journal of Clinical and Laboratory Investigation, 1998
- Fibrinolytic Variables and Cardiovascular Prognosisin Patients With Stable Angina Pectoris Treated With Verapamil or MetoprololCirculation, 1997
- Arterial and Venous Thrombosis Is Not Associated With the 4G/5G Polymorphism in the Promoter of the Plasminogen Activator Inhibitor Gene in a Large Cohort of US MenCirculation, 1997
- Plasminogen activator inhibitor 1 in thrombotic diseaseCurrent Opinion in Hematology, 1996
- Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Increased levels of tissue plasminogen activator with a low plasminogen activator inhibitor‐1 in a patient with postoperative bleedingAmerican Journal of Hematology, 1991
- Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Thrombosis after hip replacement: Relationship to the fibrinolytic systemActa Orthopaedica, 1989
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987